access your medical records
Home > Research at Avera > Clinical Trials at Avera > Clinical Trials Search Results
This phase III trial compares adding a new anti-cancer drug (venetoclax) to the usual treatment (ibrutinib plus obinutuzumab) in older patients with chronic lymphocytic leukemia who have not received previous treatment.
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior induction regimens.
© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.